Xometry (NASDAQ:XMTR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.12 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.05, FiscalAI reports. The company had revenue of $205.14 million for the quarter, compared to the consensus estimate of $188.46 million. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The firm's revenue for the quarter was up 35.9% compared to the same quarter last year. During the same quarter last year, the company earned ($0.05) earnings per share.
Here are the key takeaways from Xometry's conference call:
- Record Q1 financials: Revenue was $205M (+36% YoY) with marketplace revenue up 40%, marketplace gross profit up 53% and adjusted EBITDA of $10.5M, while cash and equivalents totaled $224M with positive operating and free cash flow.
- Raised outlook: Management raised Q2 revenue guidance to $214M–$216M (32%–33% YoY) and lifted full-year revenue growth to at least 27%–28% with a target of at least 20% incremental adjusted EBITDA margin for 2026.
- Siemens strategic partnership and $50M investment: Siemens will embed Xometry’s AI/pricing/sourcing inside its Xcelerator/Designcenter and invested $50M, which management says could materially expand Xometry’s global reach and lower customer acquisition costs (Siemens not yet baked into guidance).
- Product and AI-led momentum: New AI models (lead‑time model trained on ~4x data), Instant Quoting improvements, the "Name Your Part" feature, injection‑molding expansion and supplier tooling are cited as drivers of active buyers +20% and revenue per buyer +17%.
- International remains a drag with a Q1 segment adjusted EBITDA loss of $2.8M (8% of revenue) despite improvement, and services revenue is roughly flat as the Thomas ad platform/search transition continues.
Xometry Stock Performance
NASDAQ:XMTR traded up $22.10 during trading hours on Thursday, reaching $78.50. The company had a trading volume of 4,628,941 shares, compared to its average volume of 648,007. Xometry has a 1-year low of $29.60 and a 1-year high of $82.11. The firm has a market cap of $4.07 billion, a PE ratio of -64.34 and a beta of 1.01. The business's 50 day moving average price is $44.14 and its 200-day moving average price is $54.10. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.76 and a quick ratio of 3.72.
Trending Headlines about Xometry
Here are the key news stories impacting Xometry this week:
- Positive Sentiment: Record Q1 results — Xometry posted $0.12 EPS (beat ~$0.07 consensus) and $205.1M revenue, up ~36% year-over-year, signaling accelerating marketplace demand. Xometry Reports Record First Quarter 2026 Results
- Positive Sentiment: Strategic Siemens partnership and investment — Siemens will embed Xometry’s AI-native manufacturability, pricing and sourcing intelligence into Siemens Xcelerator and is making an approximately $50M minority investment, expanding Xometry’s reach into Siemens’ global engineering customer base. Siemens and Xometry partner to bring expanded AI-native supply chain intelligence to Siemens Xcelerator
- Positive Sentiment: Raised Q2 revenue target — management issued revenue guidance of $214M–$216M for Q2 versus consensus near $197.6M, implying continued demand strength and near-term revenue upside. Xometry Reports Record First Quarter 2026 Results
- Neutral Sentiment: Analyst expectations — consensus still models a negative full-year EPS (around -$0.21), so the market will watch whether margin progress and the Siemens relationship convert into sustained profitability.
- Negative Sentiment: Profitability and financial metrics remain a risk — Xometry reported a negative net margin (~-8.99%) and negative ROE, and the company remains unprofitable on a GAAP basis; execution risk remains as it scales. Listen to Conference Call / Earnings
Wall Street Analyst Weigh In
Several research firms recently commented on XMTR. Royal Bank Of Canada reduced their price objective on shares of Xometry from $64.00 to $55.00 and set a "sector perform" rating for the company in a research note on Wednesday, February 25th. Cantor Fitzgerald raised Xometry from a "neutral" rating to an "overweight" rating and set a $62.00 price objective for the company in a research report on Thursday, April 30th. Weiss Ratings restated a "sell (e+)" rating on shares of Xometry in a research note on Wednesday, January 21st. Zacks Research raised Xometry from a "strong sell" rating to a "hold" rating in a research report on Monday, March 2nd. Finally, Citigroup decreased their price target on Xometry from $75.00 to $65.00 and set a "buy" rating for the company in a research note on Wednesday, February 25th. Six equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $62.25.
Get Our Latest Stock Report on Xometry
Insider Buying and Selling at Xometry
In other news, insider Subir Dutt sold 2,410 shares of the business's stock in a transaction dated Thursday, February 26th. The shares were sold at an average price of $43.47, for a total transaction of $104,762.70. Following the completion of the sale, the insider owned 88,633 shares of the company's stock, valued at $3,852,876.51. The trade was a 2.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Emily Rollins sold 1,000 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $42.02, for a total transaction of $42,020.00. Following the completion of the transaction, the director directly owned 15,136 shares in the company, valued at $636,014.72. This represents a 6.20% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 67,491 shares of company stock worth $2,997,263. 9.66% of the stock is currently owned by insiders.
Institutional Trading of Xometry
Several large investors have recently made changes to their positions in XMTR. Bridgefront Capital LLC purchased a new stake in Xometry during the 4th quarter valued at about $261,000. CIBC Bancorp USA Inc. purchased a new stake in Xometry in the third quarter valued at $253,000. Brevan Howard Capital Management LP purchased a new stake in Xometry in the 2nd quarter valued at about $242,000. Tower Research Capital LLC TRC raised its stake in shares of Xometry by 830.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,130 shares of the company's stock valued at $241,000 after acquiring an additional 6,364 shares during the period. Finally, Opal Capital LLC purchased a new stake in Xometry in the fourth quarter valued at approximately $213,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.
Xometry Company Profile
(
Get Free Report)
Xometry, Inc NASDAQ: XMTR operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.
Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xometry, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.
While Xometry currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.